Furthermore, we observed that systemic levels of IL-8 and IL-10 differed according to the tumor grade, with higher levels in patients with glioblastoma (WHO grade IV) compared to lower grade glioma (WHO grade II–III). Here, IL10 is linked to neoplasm.